Evolutionary analysis and distribution of type III effector genes in pathogenic Escherichia coli from human, animal and food sources.

Molecular analysis of Shiga toxin-producing Escherichia coli (STEC) from different sources is considered as a major approach to assess their risk potential. However, only limited data are available about the correlation of evolutionary relationship, the presence of major virulence factor genes and the putative risk of an STEC strain for human infection. In this study, we analysed the evolutionary relationship of 136 pathogenic E. coli strains from human, animal and food sources by multi-locus sequence typing (MLST) and molecular subtyping of their Shiga toxin (stx) and intimin (eae) genes. Moreover, the distribution of three type III effector genes, encoded within the locus of enterocyte effacement (LEE), and 16 effector genes, which are encoded outside the LEE, was analysed. One hundred and five strains from different sources harboured 5-15 of the analysed non-LEE-encoded effector genes. In 101 of these strains, the LEE genes eae, map, espF and espG were present simultaneously. Thirty-one isolates deriving mainly from food and patients suffering from haemolytic uraemic syndrome (HUS) were eae-negative and did not carry any of the analysed effector genes. By combination of MLST and virulence gene data, we defined five genetic clusters. Within these clusters a clear-cut affiliation of particular sequence types and the occurrence of certain effector genes was observed. However, in contrast to other studies, a significant correlation between the amount and type of effector genes and the risk to cause HUS could not be demonstrated.

[1]  A. Weiss,et al.  EspM inhibits pedestal formation by enterohaemorrhagic Escherichia coli and enteropathogenic E. coli and disrupts the architecture of a polarized epithelial monolayer , 2010, Cellular microbiology.

[2]  T. A. Gomes,et al.  Prevalence and Characteristics of the O122 Pathogenicity Island in Typical and Atypical Enteropathogenic Escherichia coli Strains , 2010, Journal of Clinical Microbiology.

[3]  T. Meyer,et al.  The Type III Secretion Effector NleE Inhibits NF-κB Activation , 2010, PLoS pathogens.

[4]  S. Gruenheid,et al.  The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli , 2010, Cellular microbiology.

[5]  B. Finlay,et al.  Bacterial Effector Binding to Ribosomal Protein S3 Subverts NF-κB Function , 2009, PLoS pathogens.

[6]  Masahira Hattori,et al.  Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli , 2009, Proceedings of the National Academy of Sciences.

[7]  Tetsuya Hayashi,et al.  Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue. , 2009, Microbiology.

[8]  A. Fruth,et al.  Molecular Analysis of Virulence Profiles and Shiga Toxin Genes in Food-Borne Shiga Toxin-Producing Escherichia coli , 2009, Applied and Environmental Microbiology.

[9]  A. Mellmann,et al.  Shiga Toxin, Cytolethal Distending Toxin, and Hemolysin Repertoires in Clinical Escherichia coli O91 Isolates , 2009, Journal of Clinical Microbiology.

[10]  T. Whittam,et al.  Shiga Toxin–producing Escherichia coli Strains Negative for Locus of Enterocyte Effacement , 2009, Emerging infectious diseases.

[11]  B. Kenny,et al.  The effector repertoire of enteropathogenic E. coli: ganging up on the host cell , 2009, Current opinion in microbiology.

[12]  Tetsuya Hayashi,et al.  Complete Genome Sequence and Comparative Genome Analysis of Enteropathogenic Escherichia coli O127:H6 Strain E2348/69 , 2008, Journal of bacteriology.

[13]  M. Hattori,et al.  Systematic Identification and Sequence Analysis of the Genomic Islands of the Enteropathogenic Escherichia coli Strain B171-8 by the Combined Use of Whole-Genome PCR Scanning and Fosmid Mapping , 2008, Journal of bacteriology.

[14]  M. Woodward,et al.  Role of NleH, a Type III Secreted Effector from Attaching and Effacing Pathogens, in Colonization of the Bovine, Ovine, and Murine Gut , 2008, Infection and Immunity.

[15]  A. Mellmann,et al.  Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.

[16]  B. Finlay,et al.  Genomic O Island 122, Locus for Enterocyte Effacement, and the Evolution of Virulent Verocytotoxin-Producing Escherichia coli , 2008, Journal of bacteriology.

[17]  J. Nougayrède,et al.  EspF Interacts with Nucleation-Promoting Factors To Recruit Junctional Proteins into Pedestals for Pedestal Maturation and Disruption of Paracellular Permeability , 2008, Infection and Immunity.

[18]  E. Caron,et al.  EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis , 2008, Cellular microbiology.

[19]  B. Finlay,et al.  Characterization of the NleF effector protein from attaching and effacing bacterial pathogens. , 2008, FEMS microbiology letters.

[20]  M. Pallen,et al.  Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens , 2008, Cellular microbiology.

[21]  B. Finlay,et al.  Molecular Analysis as an Aid To Assess the Public Health Risk of Non-O157 Shiga Toxin-Producing Escherichia coli Strains , 2008, Applied and Environmental Microbiology.

[22]  Tetsuya Hayashi,et al.  Global Regulation by Horizontally Transferred Regulators Establishes the Pathogenicity of Escherichia coli , 2008, DNA research : an international journal for rapid publication of reports on genes and genomes.

[23]  T. Whittam,et al.  Applicability of Phylogenetic Methods for Characterizing the Public Health Significance of Verocytotoxin-Producing Escherichia coli Strains , 2007, Applied and Environmental Microbiology.

[24]  A. Maurelli,et al.  The NleE/OspZ Family of Effector Proteins Is Required for Polymorphonuclear Transepithelial Migration, a Characteristic Shared by Enteropathogenic Escherichia coli and Shigella flexneri Infections , 2007, Infection and Immunity.

[25]  Tetsuya Hayashi,et al.  Distribution, Functional Expression, and Genetic Organization of Cif, a Phage-Encoded Type III-Secreted Effector from Enteropathogenic and Enterohemorrhagic Escherichia coli , 2007, Journal of bacteriology.

[26]  R. Schekman,et al.  The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. , 2007, Cell host & microbe.

[27]  H. Schmidt,et al.  Molecular Characterization and Distribution of Genes Encoding Members of the Type III Effector NleA Family among Pathogenic Escherichia coli Strains , 2007, Journal of Clinical Microbiology.

[28]  B. Finlay,et al.  Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens , 2007, Cellular microbiology.

[29]  Tetsuya Hayashi,et al.  An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination , 2006, Proceedings of the National Academy of Sciences.

[30]  F. Dziva,et al.  Identification and characterization of EspK, a type III secreted effector protein of enterohaemorrhagic Escherichia coli O157:H7. , 2006, FEMS microbiology letters.

[31]  B. Finlay,et al.  Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map) , 2006, Cellular microbiology.

[32]  B. Finlay,et al.  Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. , 2006, The Journal of infectious diseases.

[33]  Daniel Falush,et al.  Sex and virulence in Escherichia coli: an evolutionary perspective , 2006, Molecular microbiology.

[34]  M. Kelly,et al.  Essential Role of the Type III Secretion System Effector NleB in Colonization of Mice by Citrobacter rodentium , 2006, Infection and Immunity.

[35]  A. Friedrich,et al.  New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. , 2006, Seminars in thrombosis and hemostasis.

[36]  A. Roe,et al.  A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. , 2006, FEMS microbiology letters.

[37]  G. Frankel,et al.  Enteropathogenic and Enterohemorrhagic Escherichia coli Infections: Translocation, Translocation, Translocation , 2005, Infection and Immunity.

[38]  L. Beutin,et al.  Genetic Analysis of Enteropathogenic and Enterohemorrhagic Escherichia coli Serogroup O103 Strains by Molecular Typing of Virulence and Housekeeping Genes and Pulsed-Field Gel Electrophoresis , 2005, Journal of Clinical Microbiology.

[39]  É. Oswald,et al.  TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin‐cytoskeleton † , 2004, Cellular microbiology.

[40]  B. Kenny,et al.  Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein , 2004, Molecular microbiology.

[41]  C. Jenkins,et al.  Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates. , 2004, Journal of medical microbiology.

[42]  J. Nougayrède,et al.  Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway , 2004, Cellular microbiology.

[43]  C. Sasakawa,et al.  Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF‐H1 , 2004, The EMBO journal.

[44]  J. Leong,et al.  EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. , 2004, Developmental cell.

[45]  W. Hanage,et al.  eBURST: Inferring Patterns of Evolutionary Descent among Clusters of Related Bacterial Genotypes from Multilocus Sequence Typing Data , 2004, Journal of bacteriology.

[46]  X. Tu,et al.  Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition , 2003, Molecular microbiology.

[47]  J. Kaper,et al.  Association of Genomic O Island 122 of Escherichia coli EDL 933 with Verocytotoxin-Producing Escherichia coli Seropathotypes That Are Linked to Epidemic and/or Serious Disease , 2003, Journal of Clinical Microbiology.

[48]  L. Beutin,et al.  Genetic Diversity of Intimin Genes of Attaching and Effacing Escherichia coli Strains , 2002, Journal of Clinical Microbiology.

[49]  R. Strugnell,et al.  Characterization and evidence of mobilization of the LEE pathogenicity island of rabbit‐specific strains of enteropathogenic Escherichia coli , 2002, Molecular microbiology.

[50]  B. Kenny,et al.  Co‐ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules , 2002, Molecular microbiology.

[51]  B. P. McNamara,et al.  Role of EspF in host cell death induced by enteropathogenic Escherichia coli , 2001, Cellular microbiology.

[52]  N. W. Davis,et al.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7 , 2001, Nature.

[53]  B. Kenny,et al.  Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria , 2000, Cellular microbiology.

[54]  T. McDaniel,et al.  The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69 , 1998 .

[55]  M. Achtman,et al.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  G. Dougan,et al.  Detection of Intimins α, β, γ, and δ, Four Intimin Derivatives Expressed by Attaching and Effacing Microbial Pathogens , 1998, Journal of Clinical Microbiology.

[57]  J. Nataro,et al.  Diarrheagenic Escherichia coli , 1998, Clinical Microbiology Reviews.

[58]  B. Finlay,et al.  Enteropathogenic E. coli (EPEC) Transfers Its Receptor for Intimate Adherence into Mammalian Cells , 1997, Cell.

[59]  A. Agresti.  [A Survey of Exact Inference for Contingency Tables]: Rejoinder , 1992 .

[60]  S. Maguire,et al.  A simple method for the preparation of plasmid and chromosomal E. coli DNA. , 1989, Nucleic acids research.

[61]  A. Fruth,et al.  Subtyping of pathogenic Escherichia coli strains using flagellar (H)-antigens: serotyping versus fliC polymorphisms. , 2003, International journal of medical microbiology : IJMM.

[62]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.

[63]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .

[64]  M. P. Jackson,et al.  Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. , 1992, Current topics in microbiology and immunology.